FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma.

Amplification of the fibroblast growth factor receptor 1 (FGFR1) is believed to predict response to multi-kinase inhibitors targeting FGFR1. Esophageal cancer is an aggressive disease, for which novel targeted therapies are highly warranted.This study was designed to investigate the prevalence and c...

Full description

Bibliographic Details
Main Authors: Katharina von Loga, Jule Kohlhaussen, Lia Burkhardt, Ronald Simon, Stefan Steurer, Susanne Burdak-Rothkamm, Frank Jacobsen, Guido Sauter, Till Krech
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4640518?pdf=render